CTRI/2023/07/055556
Not yet recruiting
Phase 4
Intranasal fentanyl as add-on therapy in screening of retinopathy of prematurity - A double blind randomized control trial. - NI
DR SANDIP KUMAR SAH0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Health Condition 1: H36- Retinal disorders in diseases classified elsewhere
- Sponsor
- DR SANDIP KUMAR SAH
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Preterm infants heaving gestational age
- •\<34 weeks or birth weight \< 2000 gm were screened for retinopathy of prematurity
Exclusion Criteria
- •Unstable neonates ( ventilate) and sedated neonate
- •Neonates with C/I for fentanyl
- •Neonates planned for surgery and neonate with congenital defects, and neurological disfunction
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
The efficacy of intranasal fentanyl as an adjunct for pain management in retinopathy of prematurity screeningEfficacy of intranasal fentanyl drops as an adjunct for pain management in retinopathy of prematurity screening.Pain, retinopathy of prematurity, intranasal fentanylTCTR20230109003Bhumibol Adulyadej Hospital49
Not yet recruiting
Not Applicable
Efficacy of intranasal fentanyl for the treatment of moderate to severe pain in adult patients in the emergency departmentACTRN12613000652774Peninsula Health150
Completed
Phase 4
Intranasal Fentanyl as an Analgesic for Cystoscopic ProceduresPainNCT01708122Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center71
Completed
Phase 3
Efficacy and Safety of Intranasal Fentanyl in the Treatment of Breakthrough Pain (FT-018-IM)CancerNCT00362583Nycomed100
Completed
Phase 2
The Use of Intranasal Fentanyl for the Treatment of Incident Dyspnea in Congestive Heart Failure: A Prospective TrialDyspneaCongestive Heart FailureNCT02454751St. Boniface Hospital8